CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Open-market sale Chief Scientific Officer sold 68,315 shares at an average $45.00 ($3,074,387)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $45.00 ($675,000)
- 4 Open-market sale Director sold 755 shares at $37.37 ($28,214)
- 4 Grant or award Director acquired 522 shares (grant or award)
- 4 Grant or award Director acquired 251 shares (grant or award)
- 4 Grant or award Director acquired 220 shares (grant or award)
- 4 Grant or award Director acquired 339 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $37.98 ($569,666)
- 4 Open-market sale Director sold 755 shares at $37.19 ($28,078)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 424B4 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
Page 23 of 28 · 549 filings